Mariner
ARCT icon

Mariner’s Arcturus Therapeutics ARCT Stock Holding History

Mariner’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
+20,555
New +$162K ﹤0.01% 3262

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mariner's ARCT Position: Q2 2026 in Review

Mariner opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 20,555 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #3262 among its holdings.

135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Mariner held 20,555 shares of Arcturus Therapeutics worth $138K as of Q2 2026.
  • Arcturus Therapeutics was a new Mariner position in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3262 holding.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.